Literature DB >> 32774042

What factors contribute to Choi IV sequelae? A retrospective analysis of 15 septic hips.

Anil Agarwal1, Prateek Rastogi1.   

Abstract

PURPOSE: Choi IV sequela is one of the most severe outcomes of septic hips. We undertook a retrospective chart review of 15 such hips in 13 patients to identify factors contributing to the formation of this sequelae.
METHODS: The study specifically focused on patient demographics (patient's age; time to arthrotomy from initial symptoms; causative organism; post arthrotomy duration when Choi IV changes were obvious) and radiological findings at the time of arthrotomy.
RESULTS: The average patient's age at time of infection was 2.9 years. Five children were infants. The time to arthrotomy from initial symptoms was mean 21.6 days. Multifocal involvement was seen in 2 patients. Concurrent arthritis and osteomyelitis was present in 8 (53%) and pathological subluxation or dislocation in 9 hips (60%). Methicillin-sensitive Staphylococcus aureus was isolated in 7 and Methicillin-resistant Staphylococcus aureus in 4 patients. The Choi IV findings were established on average 3.8 months post arthrotomy.
CONCLUSIONS: Delay in treatment, post septic dislocation and concurrent femoral osteomyelitis were factors associated with Choi IV septic sequelae. The pathology occurred irrespective of age.
© 2020 Delhi Orthopedic Association. All rights reserved.

Entities:  

Keywords:  Child; Choi IV; Septic hip; Sequelae; Suppurative

Year:  2020        PMID: 32774042      PMCID: PMC7394802          DOI: 10.1016/j.jcot.2020.05.016

Source DB:  PubMed          Journal:  J Clin Orthop Trauma        ISSN: 0976-5662


  11 in total

Review 1.  Operative reconstruction for septic arthritis of the hip.

Authors:  In Ho Choi; Won Joon Yoo; Tae-Joon Cho; Chin Youb Chung
Journal:  Orthop Clin North Am       Date:  2006-04       Impact factor: 2.472

2.  Physeal separation and complete resorption of femoral head associated with chronic osteomyelitis of femoral diaphysis in a young child: rare case report.

Authors:  Praveen K Pandey; Inder Pawar; Jyoti Gupta
Journal:  J Pediatr Orthop B       Date:  2016-11       Impact factor: 1.041

3.  Sequelae and reconstruction after septic arthritis of the hip in infants.

Authors:  I H Choi; P D Pizzutillo; J R Bowen; R Dragann; T Malhis
Journal:  J Bone Joint Surg Am       Date:  1990-09       Impact factor: 5.284

4.  Surgical treatment of the severe sequelae of infantile septic arthritis of the hip.

Authors:  In Ho Choi; Yong Woon Shin; Chin Youb Chung; Tae-Joon Cho; Won Joon Yoo; Duk Yong Lee
Journal:  Clin Orthop Relat Res       Date:  2005-05       Impact factor: 4.176

5.  Late sequelae of hip septic arthritis in children.

Authors:  Taghi Baghdadi; Sadegh Saberi; Amir Sobhani Eraghi; Aidin Arabzadeh; Shirin Mardookhpour
Journal:  Acta Med Iran       Date:  2012

6.  Late sequelae of septic arthritis of the hip in infancy and childhood.

Authors:  R R Betz; D R Cooperman; J M Wopperer; R D Sutherland; J J White; H W Schaaf; M R Aschliman; I H Choi; J R Bowen; R Gillespie
Journal:  J Pediatr Orthop       Date:  1990 May-Jun       Impact factor: 2.324

7.  Sequelae of septic arthritis of the hip in children: a new classification and a review of 41 hips.

Authors:  Edilson Forlin; Carlo Milani
Journal:  J Pediatr Orthop       Date:  2008 Jul-Aug       Impact factor: 2.324

8.  Septic arthritis of the hip in children: poor results after late and inadequate treatment.

Authors:  G Fabry; E Meire
Journal:  J Pediatr Orthop       Date:  1983-09       Impact factor: 2.324

9.  Classification and surgical management of the severe sequelae of septic hips in children.

Authors:  L Hunka; S E Said; D A MacKenzie; E J Rogala; R L Cruess
Journal:  Clin Orthop Relat Res       Date:  1982 Nov-Dec       Impact factor: 4.176

10.  Suppurative arthritis of hip in a walking child: Effect of patient's age, delay in surgical drainage, and organism virulence.

Authors:  Anil Agarwal; Vimal Kumar Kh
Journal:  J Orthop Surg (Hong Kong)       Date:  2020 Jan-Apr       Impact factor: 1.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.